Primary Central Nervous System Tumors Pathogenesis and Therapy 1st Editon 2013 Softbound at Meripustak

Primary Central Nervous System Tumors Pathogenesis and Therapy 1st Editon 2013 Softbound

Books from same Author: Andrew D. Norden, David A. Reardon, Patrick C. Y. Wen

Books from same Publisher: Humana Press

Related Category: Author List / Publisher List


  • Retail Price: ₹ 25255/- [ 5.00% off ]

    Seller Price: ₹ 23992

Sold By: Book Upload      Click for Bulk Order

Offer 1: Get ₹ 111 extra discount on minimum ₹ 500 [Use Code: Bharat]

Offer 2: Get 5.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 5.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available



Click for International Orders
  • Provide Fastest Delivery

  • 100% Original Guaranteed
  • General Information  
    Author(s)Andrew D. Norden, David A. Reardon, Patrick C. Y. Wen
    PublisherHumana Press
    Edition1st Edition
    ISBN9781617797231
    Pages570
    BindingSoftbound
    LanguageEnglish
    Publish YearJanuary 2013

    Description

    Humana Press Primary Central Nervous System Tumors Pathogenesis and Therapy 1st Editon 2013 Softbound by Andrew D. Norden, David A. Reardon, Patrick C. Y. Wen

    This comprehensive, yet practical, text is a ready collection of the most up-to-date information on primary CNS tumors. Authored by a carefully selected group of the world’s leading clinicians and scientists, the book is divided into three sections. The opening chapters cover general principles, including epidemiology, pathogenesis, tumor stem cells, supportive care, complications of therapy, and quality of life. The remaining two sections are comprised of treatment-oriented chapters covering the spectrum of gliomas and rarer tumor types. Each of these chapters presents multi-disciplinary therapeutic approaches and addresses specific disease concerns. Throughout, the authors incorporate the cutting-edge advances in molecular biology and genomics that are revolutionizing neuro-oncology. The result is an important clinical resource which provides evidence-based data and interpretation essential to intelligent therapeutic decision making. Part I: General Principles.- 1 - Epidemiology and Risk Factors.- 2 - Molecular Pathogenesis.- 3 - Brain Tumor Stem Cells.- 4 - Principles of Supportive Care.- 5 - Principles of Clinical Trial Design and Response Assessment.- 6 - Complications of Therapy.- 7 – Neuropsychological Function and Quality of Life.- Part II: Gliomas.- 8 - Low-Grade Gliomas.- 9 - High-Grade Astrocytomas.- 10 - Anaplastic Oligodendrogliomas and Mixed Gliomas.- 11 - Ependymomas.- 12 - Uncommon Gliomas in Adults: Brainstem Gliomas, Pilocytic Astrocytomas and Pleomorphic Xanthoastrocytomas.- Part III: Other Tumor Types.- 13 - Pediatric Tumors.- 14 - Primary Central Nervous System Lymphoma.- 15 - Meningiomas.- 16 - Pituitary Adenomas.- 17 - Vestibular Schwannomas.- 18 - Medulloblastomas.- 19 - Pineal Region Tumors.- 20 - Genetic Syndromes.- 21 - Rare Tumors.- 22 - Spinal Tumors.